JETEMA, Co., Ltd.
216080.KQ
Get informed when a big investor buys or sells
+ FollowMarket Cap$219.53B
Close$
Share Statistics
| Market cap | $219.53 Billion |
|---|---|
| Enterprise Value | $322.78 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-184.02 |
| Beta | 0.66 |
| Outstanding Shares | 37,270,000 |
Return
| Return on Equity | -1.63% |
|---|---|
| Return on Assets | -0.55% |
| Return on Invested Capital | 7.44% |
Valuation & Multiples
| P/E Ratio | -151.98 |
|---|---|
| PEG | 87.13 |
| Price to Sales | 2.87 |
| Price to Book Ratio | 2.73 |
| Enterprise Value to Revenue | 4.21 |
| Enterprise Value to EBIT | 27.03 |
| Enterprise Value to Net Income | -243 |
| Total Debt to Enterprise | 0.44 |
| Debt to Equity | 1.72 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
November 18, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About JETEMA, Co., Ltd.
227 employees
CEO: Jeong Sun Nam Based in Wonju, South Korea, JETEMA, Co., Ltd. is a dynamic bio-venture firm dedicated to the innovation and development of pharmaceuticals and medical technologies. Their comprehensive portfolio encompasses a range of advanced solutions...